Publisher | Springer Nature |
Language | English |
Book type | Paperback |
Utgiven | 2016-10-22 |
Edition | 1 |
Pages | 390 |
ISBN | 9783319358512 |
Kategori(er) |
Nature science & Tech ↳ Biology |
The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.
This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.
So far, we have reused
2
3
3
1
7
8
9
books.
Sweden's friendliest and environmental friendliest bookshop with the lowest priced textbooks.
This is our ambition, and we do what it takes to get there. We are here to help students to save and earn money on their textbooks while we at the same time save the environment. We were started in 2005 by two students and have since strived to constantly make it easier to buy and sell used textbooks for as many as possible.
Subscribe to receive our best student tips, offers and promotions.
Read more about how we handle personal data in our privacy policy.
Sök efter bokens streckkod/isbn.